Sigma Healthcare Stock

Sigma Healthcare ROE

The Return on Equity (ROE) of Sigma Healthcare (SIG.AX) as of Aug 14, 2026 is 11.35 %. In the previous year, Return on Equity (ROE) was -1.65 % — a change of -786.77% (higher).

ROE

11.35 %

YoY

-786.77%

Last updated:

In 2026, Sigma Healthcare's return on equity (ROE) was 11.35 %, a -786.77% increase from the -1.65 % ROE in the previous year.

Access this data via the Eulerpool API

Sigma Healthcare Stock analysis

What does Sigma Healthcare do? Sigma Healthcare Ltd is an Australian company that has been operating in the healthcare industry for over 100 years. Founded in 1911 as a local pharmacy in Melbourne, the company has since become a leading provider of pharmaceutical services in Australia. The company's core business is the delivery of pharmacy products and services to pharmacies and medical practices across Australia. Sigma Healthcare Ltd supplies over 4,000 independent retailers as well as numerous large chains and department store pharmacies. Sigma Healthcare Ltd also offers various healthcare services, such as consulting, training, and support in medication delivery. Divided into different divisions, Sigma Healthcare Ltd offers a wide portfolio of products. In the pharmaceutical products division, the company distributes national and international medications, both prescription and over-the-counter. Additionally, health and personal care products such as medical devices, supplements, vitamins, and minerals are available. The general products division offers a variety of non-food products, such as personal care products, wellness products, hygiene products, cleaning agents, cosmetics, and household products. Another important division is the pharmacy management system, which supports pharmacies in managing their business and billing processes. The system complements the existing offering with additional features, such as inventory management, prescription processing, accounting, and customer loyalty. Innovation plays a central role at Sigma Healthcare Ltd. The company invests significant resources in researching and developing new products and services to continuously improve the customer experience and meet the ever-growing demands of the industry. The company benefits from close relationships with leading manufacturers and international organizations. Partnerships are another crucial aspect of Sigma Healthcare Ltd's business model. The company works closely with manufacturers, retailers, pharmacists, and other partners to jointly create innovative solutions and products to enhance the customer experience. In recent years, Sigma Healthcare Ltd has also pursued a significant growth strategy, such as acquiring companies that complement its existing portfolio. This includes the acquisition of API in 2020 and Discount Drug Stores in 2018, which have greatly expanded the offerings of Sigma Healthcare Ltd. Overall, Sigma Healthcare Ltd is an important company in the Australian healthcare industry. With a wide range of products and services, a strong culture of innovation, and significant partnerships with industry players, the company will continue to establish itself as a key player in healthcare and continuously improve the customer experience. Sigma Healthcare is one of the most popular companies on Eulerpool.

ROE Details

Decoding Sigma Healthcare's Return on Equity (ROE)

Sigma Healthcare's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Sigma Healthcare's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Sigma Healthcare's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Sigma Healthcare’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Sigma Healthcare stock

Return on Equity (ROE) of Sigma Healthcare is 11.35 % in 2026.

Return on Equity (ROE) of Sigma Healthcare changed from -1.65 % to 11.35 %, representing a -786.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Sigma Healthcare since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Sigma Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Sigma Healthcare

All Key Metrics — Sigma Healthcare